Filter
4391
Filtered Results: 4391
Text search:
drug
strategy
Featured
Recommendations
380
New Publications
1263
Language
Document type
No document type
2739
Studies & Reports
681
Guidelines
505
Manuals
166
Strategic & Response Plan
158
Fact sheets
53
Training Material
45
Situation Updates
22
Infographics
13
Resource Platforms
5
Brochures
2
Dashboards/Maps
1
App
1
Countries / Regions
India
223
Kenya
152
Global
145
Uganda
113
South Africa
112
Ethiopia
108
Western and Central Europe
100
Nigeria
94
Nepal
86
Liberia
82
Zambia
77
Sierra Leone
75
Malawi
74
Tanzania
73
Myanmar / Burma
72
Africa
66
Latin America and the Carribbean
66
Bangladesh
61
Ghana
58
Rwanda
53
Eastern Europe
49
Namibia
44
Ukraine
42
Philippines
41
Indonesia
40
Cambodia
37
Asia
37
Zimbabwe
36
South–East Asia Region
33
Lesotho
31
Botswana
25
Russia
24
Syria
23
Congo, Democratic Republic of
20
Colombia
18
Senegal
17
Mozambique
17
East and Southern Africa
16
Eswatini/ Swaziland
16
Burkina Faso
15
West and Central Africa
15
Brazil
15
Middle East and North Africa
14
South Sudan
13
Eastern Europe and Central Asia
12
Cameroon
11
Albania
11
Tajikistan
10
Thailand
10
USA
10
Venezuela
10
Pakistan
10
Guinea
9
Haiti
9
Sudan
9
Georgia
9
Germany
8
Peru
7
Western Pacific Region
7
Vietnam
7
Benin
6
Laos
6
Afghanistan
6
Argentina
6
Iraq
5
North Macedonia
4
Mexico
4
Turkey
4
China
4
Jordan
4
Southern Africa
4
Lebanon
4
Moldova
4
Sri Lanka
4
Yemen
4
Central African Republic
4
Timor Leste/ East Timor
3
El Salvador
3
Iran
3
Armenia
3
Paraguay
3
Jamaica
3
Bolivia
3
Bhutan
3
Somalia
3
Estonia
2
Kyrgyzstan
2
Uzbekistan
2
Morocco
2
Hungary
2
Saudi Arabia
2
North America
2
United Kingdom
2
Portugal
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Honduras
2
Libya
2
Madagascar
2
North Korea
1
Switzerland
1
Serbia
1
Gambia
1
Kazakhstan
1
Chile
1
Canada
1
Fiji
1
Austria
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Nicaragua
1
Romania
1
Greece
1
Palestine
1
Poland
1
Mali
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1792
Clinical Guidelines
384
Public Health
242
Women & Child Health
150
Key Resources
92
Capacity Building
51
Pharmacy & Technologies
44
Annual Report MEDBOX
1
Toolboxes
HIV
553
TB
454
Mental Health
337
AMR
238
COVID-19
168
NTDs
160
Pharmacy
109
NCDs
98
Rapid Response
79
Caregiver
71
Planetary Health
64
Ebola
63
Conflict
52
Global Health Education
48
Disability
47
Refugee
45
Health Financing Toolbox
31
Polio
21
Natural Hazards
17
Specific Hazards
14
Cholera
14
Zika
10
Social Ethics
9
Health Financing
1
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
There is an expanding market of no- and low-alcohol beverages (NoLos). However, their effects on global ethanol consumption and public health are still questioned. Policies and regulations about NoLos’ availability, acceptability and affordability are lacking and evidence about their benefits is l...
The chapter Closing the Gap: The Health Disparities of Older LGBTI People in the Americas, is part of the publication series titled ‘Decade of Healthy Aging: situation and challenges’. In order to outline the current knowledge available on the situation of health and well-being of older persons ...
WASH and Health working together: a ‘how-to’ guide for neglected tropical disease programmes
recommended
2nd edition. This toolkit provides step-by-step guidance to NTD programme managers and partners on how to engage and work collaboratively with the WASH community to improve delivery of water, sanitation and hygiene services to underserved population affected by many neglected tropical diseases. The ...
Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
The World health statistics report is the annual compilation of health and health-related indicators which has been published by the World Health Organization (WHO) since 2005. The 2023 edition reviews more than 50 health-related indicators from the Sustainable Development Goals (SDGs) and WHO’s T...
UNFPA has been implementing programming for women and girls through Women Friendly Health Spaces (WFHSs), which provide access to critical services, information and support. The WFHS is providing: psychosocial counseling services; awareness raising sessions on PSS in the community; and life skills &...
Due to high routine vaccination coverage, overall counts of diphtheria case have significantly declined in the Western Pacific Region recently. However, diphtheria is still prevalent in several countries and areas of the Region and remains a public health issue due to its high case fatality rate.
...
This checklist is for any organization or person supporting the routine use of evidence in
the process of policy-making. Evidence-informed policy-making (EIPM) is essential for achieving the Sustainable Development Goals (SDGs) and universal health coverage (UHC). Its importance is emphasized in WH...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination...
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The ...
To assess national-level responses to NCDs, WHO has implemented NCD country capacity surveys periodically since 2001. This report is the latest in that series. Since the first survey round, the NCD Country Capacity Survey (NCD CCS) has been conducted a further seven times, most recently in 2021. In ...
This report presents findings from research conducted by Economist Impact to assess the health, demographic, social and economic impacts associated with different scenarios for financing the HIV epidemic across 13 selected countries in Sub-Saharan Africa. The sponsorship of UNAIDS towards this repor...
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di...
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current treatment monitoring algorithm from the Consol...
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...
This report started with a simple question—“How can we tell how much funding is devoted to global health programs?”—and ended (more than two years later) with an answer that is far from simple. As those who have tried know well, tracking health-related funding is challenging in any setting, ...
